ClinicalTrials.govpublic full text
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
head and neck carcinoma, adenoid cystic carcinoma, lung cancer, non-small cell lung cancer, pancreatic cancer, mesothelioma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 136329
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.